Back
Biohaven Vs. Oramed Pharmaceuticals Industry Stock Comparison
Sell
50
BHVN
Biohaven
Last Price:
46.06
Seasonality Move:
26.66%
Buy
56
ORMP
Oramed Pharmaceuticals
Last Price:
2.53
Seasonality Move:
19.43%
Sell
50
Biohaven (BHVN)
is a Sell
Is Biohaven a Buy, Sell or Hold?
- The current Biohaven [BHVN] share price is $46.06. The Score for BHVN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BHVN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Oramed Pharmaceuticals (ORMP)
is a Buy
Is Oramed Pharmaceuticals a Buy, Sell or Hold?
- The current Oramed Pharmaceuticals [ORMP] share price is $2.52. The Score for ORMP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ORMP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BHVN Stock Price Chart
ORMP Stock Price Chart
What is Oramed Pharmaceuticals's stock price today?
-
The Oramed Pharmaceuticals share price today is $2.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORMP is experiencing slight buying pressure.
BHVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.25 | Sell |
| Relative Strength Index (14 RSI): | 45.55 | Sell |
| Chaikin Money Flow: | 221430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.21 - 51.31) | Sell |
| Bollinger Bands (100): | (37.89 - 50.17) | Buy |
ORMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 64.8 | Buy |
| Chaikin Money Flow: | 57574 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.28 - 2.42) | Buy |
| Bollinger Bands (100): | (2.3 - 2.48) | Buy |
BHVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.62 | Buy |
| 20-day SMA: | 47.69 | Sell |
| 50-day SMA: | 49.58 | Sell |
| 200-day SMA: | 43.63 | Buy |
| 8-day EMA: | 45.66 | Buy |
| 20-day EMA: | 47.02 | Sell |
| 50-day EMA: | 47.21 | Sell |
| 200-day EMA: | 42.31 | Buy |
ORMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.41 | Buy |
| 20-day SMA: | 2.34 | Buy |
| 50-day SMA: | 2.36 | Buy |
| 200-day SMA: | 2.48 | Buy |
| 8-day EMA: | 2.42 | Buy |
| 20-day EMA: | 2.37 | Buy |
| 50-day EMA: | 2.37 | Buy |
| 200-day EMA: | 2.49 | Buy |
Biohaven Earnings Growth & BHVN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.72 per share, and an increase next year of $2.70 per share.
Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.
Biohaven Technical Analysis
| Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oramed Pharmaceuticals Technical Analysis
| Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||